The pharmaceutical biotechnology content of pharmacy programs within Europe: A survey

Walsh, G. and Muller, R. (2007) The pharmaceutical biotechnology content of pharmacy programs within Europe: A survey. Pharmacy Education, 7 (1). pp. 27-33. ISSN 15602214 (ISSN)

[img] Text
Walsh and Muller 2007.pdf

Download (91kB)
Official URL:


Genetic engineering and allied technologies have underpinned the development of a range of pharmaceutical products of modern biotechnology, collectively termed biopharmaceuticals. Twenty-five percent of all new drugs now approved are biopharmaceuticals and some 140 such products have gained marketing approval. Given the increasing prominence of this class of therapeutic product, it is of interest to survey the pharmaceutical biotechnology content of pharmacy curricula. Commissioned by the European association of pharm biotechnology (EAPB) this 13-question survey focused upon the lecture complement of biochemistry, microbiology and molecular biology, as well as the content of core pharmaceutical biotechnology taught within European undergraduate degree programs. Forty replies were obtained from different pharmacy departments across 15 European countries. The mean numbers of lecture hours delivered in biochemistry, microbiology and molecular biology were 61.8 ± 32.2, 52.4 ± 27.7 and 34 ± 16.4, respectively. For each subject, the number of lectures differed significantly between different institutions, reflected in the large standard deviation observed. Thirty-three of the 40 survey respondents (82.5%) include core or elective courses in pharmaceutical biotechnology. The mean number of lecture hours delivered was 29.9 ± 18.6 h and the courses are mainly taught in third or fourth year. Very significant variation in pharmaceutical biotechnology course content was also observed. Given the now central importance of biotechnology within the pharmaceutical sector, it is perhaps timely to consider these issues in greater detail.

Item Type: Article
Additional Information: Cited By :2; Export Date: 23 February 2015; CODEN: PLACB; Correspondence Address: Walsh, G.; Industrial Biochemistry Program, CES Department, University of Limerick, Limerick, Ireland; References: Calis, S., Approaches to education of pharmaceutical biotechnology in faculties of pharmacy (2001) Current Pharmaceutical Biotechnology, 2, pp. 143-155; Frokjaer, S., (2000) Pharmaceutical Formulation Development of Peptides and Proteins, , Taylor and Francis, Philadelphia, PA; Frokjaer, S., Otzen, D., Protein drug stability: A formulation challenge (2005) Nature Reviews Drug Discovery, 4, pp. 298-306; Glick, B.R., McMahan, J.N., (2003) Molecular Biotechnology, , ASM press, Washington, DC; Hudson, R.A., Lubawy, W.C., Knapp, K.K., The new biotechnology and biological science related instruction in colleges of pharmacy (1990) American Journal of Pharmaceutical Education, 54, pp. 61-64; Jackson, D.A., Berg, P., Symons, R.H., Biochemical method for inserting new genetic information into DNA of simian virus 40: Circular SV 40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli (1972) Proceedings of the National Academy of Sciences USA, 69, pp. 2904-2909; Kohler, G., Milstein, C., Continuous culture of fused cells secreting antibody of pre-defined specificity (1975) Nature, 256, pp. 495-497; Lobban, P.E., Kaiser, A.D., Enzymatic end to end joining of DNA molecules (1973) Journal of Molecular Biology, 78, pp. 453-471; Manning, M.C., Mitchell, J.W., Protein chemistry, a graduate course in pharmaceutical biotechnology at the University of Kansas (1991) American Journal of Pharmaceutical Education, 55, pp. 52-55; (2000) Protein Formulation and Delivery, , Marcel dekker, New York, NY; Orive, G., Hernandez, R.M., Gascon, A.R., Dominquez-Gil, A., Pedraz, J.L., Drug delivery in biotechnology: Present and future (2003) Current Opinion in Biotechnology, 14 (6), pp. 659-664; New biotechnology medicines in development (2002) Pharmaceutical Researchers and Manufacturers of America Annual Survey, , PhRMA Washington, DC; Shepard, P., (2000) Monoclonal Antibodies, p. 2000. , Oxford University Press, Oxford; Speedie, M.K., The impact of biotechnology upon pharmacy education (1990) American Journal of Pharmaceutical Education, 54, pp. 55-61; Walsh, G., Biopharmaceutical Benchmarks (2003) Nature Biotechnology, 21, pp. 865-870; Walsh, G., Core concepts suitable for education and training for the biopharmaceutical industry (2001) Drug Information Journal, 35, pp. 985-991
Uncontrolled Keywords: Biopharmaceutical curriculum; Fermentation technology; Monoclonal antibody; Pharmaceutical biotechnology education; article; biochemistry; biotechnology; curriculum; Europe; medical education; microbiology; molecular biology; pharmacy; priority journal
Depositing User: National Forum
Date Deposited: 06 Dec 2015 21:13
Last Modified: 12 Dec 2015 18:02

Actions (login required)

View Item View Item


Downloads per month over past year